Compare Noble Corporation plc (NE) vs Natera Inc. Common Stock (NTRA) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Noble Corporation plc vs Natera Inc. Common Stock — how do they compare? Noble Corporation plc trades at $43 (market cap $6.85B), while Natera Inc. Common Stock trades at $392.78 (market cap $57.03B). The key difference: Natera Inc. Common Stock is far larger — about 8.3× Noble Corporation plc's market cap, and Noble Corporation plc pays a 4.66% dividend while Natera Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Noble Corporation plc for 27 Days and Natera Inc. Common Stock for 0 Days on average.
| NE | NTRA | |
|---|---|---|
Market Cap | $6.85B | $57.03B |
Volume | 984,361 | 1,131,157 |
Sector | Energy | Health |
52-Week High | $54.37 | $425.64 |
52-Week Low | $27.45 | $179.42 |
Typical Hold Time | 27 Days | 0 Days |
Enterprise Value | $8.28B | $56.18B |
Dividend Yield | 4.66% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Noble Corporation (NE) trades at $43.42, up 1.12% today. The stock shows mixed signals with a bullish technical outlook but bearish moving averages. Recent earnings have been volatile, with Q1 2026 beating expectations but Q2 and Q4 2025 missing. Revenue declined from $3.3B in 2025 to $3.1B in 2026, and net income fell from $217M to $150M. Positive news includes a long-term drilling contract in Ghana, but the company faces an ongoing law firm investigation.
Outlook is cautious. The consensus price target of $52.00 implies potential upside, supported by a 'Buy' rating from 31% of analysts. However, declining profitability, mixed earnings history, and legal scrutiny present risks. Investors should weigh contract wins against fundamental pressures and sentiment headwinds.
NTRA trades at $395.66, down 0.53% today but remains near recent highs. The stock shows mixed technical signals with neutral momentum indicators. Fundamentally, the company demonstrates strong revenue growth ($2.31B in 2025, projected $2.7B in 2026) but continues to operate at a net loss (-$208M in 2025). Recent positive developments include FDA Breakthrough Device designation for its multi-cancer detection assay and regulatory approval in Japan for Signatera.
NTRA presents a growth story with significant analyst support (89% buy ratings) but carries execution risks. The stock trades at premium valuations (P/S 20.48) while still unprofitable. Key catalysts include clinical trial progress and international expansion, though investors face risks from ongoing losses and competitive pressures in precision medicine.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Noble Corporation plc
Noble Corporation plc is a leading offshore drilling contractor for the oil and gas industry. The company owns and operates a high-specification fleet of mobile offshore drilling units, including drillships and semi-submersibles, that are used for exploration and production activities in deepwater and harsh environments worldwide. Noble focuses on providing safe, efficient, and reliable drilling services to major and independent oil and gas companies globally.
Read more on NE →About Natera Inc. Common Stock
Natera, Inc. develops and provides cell-free DNA-based genetic testing across women's health, oncology, organ health, and rare disease, with flagship products including Panorama for noninvasive prenatal screening and Signatera for cancer recurrence monitoring.
Read more on NTRA →
